The Nation’s Ministry of Health has reported this tuesday 20 july that in the past 24 hours, 426 deaths and 15,077 new COVID-19 infections have been recorded. This data brings the total number of cases since the start of the pandemic to 4,784,219 and deaths to 102,381.
In contrast, 93,435 tests were performed from yesterday to today, with a positivity of 16.13%. Since the start of the outbreak, 18,420,915 diagnostic tests for this disease have been performed. To date, there are 260,843 active positive cases across the country and 4,420,995 recovered.
Of the total deaths reported today, 233 are men and 191 women. Two people from the province of Buenos Aires were registered without gender data.
According to the epidemiological section, there are currently 4,643 people with coronavirus in intensive care in Argentina. The bed occupancy rate at the national level is 59.2% and in the Metropolitan Area of Buenos Aires (AMBA) 56.6%.
Of the 15,077 infections, 4,737 are from the province of Buenos Aires, 862 from the city of Buenos Aires, 245 from Catamarca, 368 from Chaco, 160 from Chubut, 636 from Corrientes, 1,345 from Córdoba, 706 from Entre Ríos, 292 from Formosa , 237 from Jujuy, 301 from La Pampa, 123 from La Rioja, 464 from Mendoza, 166 from Misiones, 208 from Neuquén, 291 from Río Negro, 446 from Salta, 554 from San Juan, 150 from San Luis, 56 from Santa Cruz, 1,524 from Santa Fe, 267 from Santiago del Estero, 35 from Tierra del Fuego and 904 from Tucumán.
This morning, the Minister of Health of the City of Buenos Aires, Fernand Quiros, confirmed that the 3,500,000 doses of Moderna donated by the Joe Biden administration, that arrived in the country last Friday will be applied to minors once they are authorized by the regulatory authorities. According to the head of the health portfolio of Buenos Aires, the goal and strategy is to apply these vaccines to people under the age of 18. In this regard, Quirós recalled that there is currently “no approved vaccine in our country for children and adolescents between 12 and 17 years old”, although he acknowledged that “it is in the approval process”.
“In the United States, the Moderna vaccine is in the approval process, which is physically already in Argentina. That’s why we’re on the lookout for what the FDA (the United States Food and Drug Administration) has, and they’ll be sure to give its opinion in the coming days.Quirós said during his usual Tuesday press conference in which he provides epidemiological data.
Likewise, the minister explained that after this authorization it will be: “ANMAT, who will evaluate the documents presented and give its opinion and approval”. “When this all happens naturally and quickly, the Nation will distribute the vaccines and we will apply them to the children and adolescents indicated, starting with children with comorbidities.”he confirmed.
According to the latest update from the Nation’s Ministry of Health, 70% of people over the age of 20 are already on a dose and 54% of those over 70 have completed their schedule. 45% of the over 60s and 33.4% of the over 50s also completed their scheme.
Meanwhile, 89.4% of people over 60 and 87.5% of people over 50 have already had their first dose of the vaccine. The same happens with 86.2% of people aged 55 to 59, as well as 82.7% of those belonging to the age group between 50 and 54 years, 78% of those between 45 and 49, and 79.3% of the following group between 40 and 44 years.
As of this morning, according to the Public Vaccination Monitor, 31,193,944 doses of vaccines were distributed across the territory, while 27,825,228 were administered. Of this total, 22,342,067 people have been vaccinated with the first dose and 5,483,161 are already on the full vaccination schedule.
Of the nearly 28 million vaccinated there are 3,649,457 health professionals; 3,660,505 people associated with strategic personnel (security and armed forces, teachers and non-teaching personnel of all levels of education, responsible for the operation of the state and personnel of the penitentiary); 866,232 people aged 50 to 59 WITHOUT risk factors; 5,014,212 people aged 18 to 59 WITH risk factors; 3,556,422 people between the ages of 18 and 39 WITHOUT risk factors; 1,920,744 people aged 40 to 49 WITHOUT risk factors; and 9,089,312 people aged 60 or older.